FDA Begins Daily Publication of Adverse Event Data

The move is part of FDA's strategy to streamline its adverse event reporting systems in an attempt to make it more efficient.

The FDA has begun daily publication of “adverse event data from the FDA Adverse Event Reporting System (FAERS).”

FAERS is “the FDA's primary database for collecting and analyzing adverse event reports, serious medication errors, and product quality complaints for prescription drugs and therapeutic biologics, containing reports submitted by healthcare professionals, consumers, and manufacturers.”

FDA is broadly attempting a “data modernization strategy to streamline all of its adverse event reporting systems and increase reporting frequency across all systems to identify safety signals faster.”

FDA commissioner Marty Makary said that this initiative is meant to close the waiting period people face when reporting adverse events, “streamlining the process from start to finish.”

The public can “view the latest adverse event data on the FAERS Public Dashboard. Healthcare professionals and consumers are encouraged to report adverse events to the FDA’s MedWatch site.”

About the Author

Matt MacKenzie

Matt MacKenzie

Associate Editor

Matt MacKenzie is Senior Staff Writer and Associate Editor of Healthcare Purchasing News (HPN), where he leads daily news coverage and contributes in-depth features on healthcare supply chain, sterile processing, infection prevention and clinical operations. Through industry reporting and expert interviews, he examines the trends, technologies and operational challenges shaping healthcare purchasing and patient care. 

Sign up for our eNewsletters
Get the latest news and updates